Report cover image

Global Statin Industry Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 202 Pages
SKU # APRC20283778

Description

Summary

According to APO Research, The global Statin Industry market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Statin Industry is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Statin Industry is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Statin Industry is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Statin Industry is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Statin Industry include CHIA TAI TIANQING, Zhejiang Jingxin Pharmaceutical, Shanghai Shyndec Pharmaceutical, Henan Topfond Pharmaceutical, Novartis, Merck, LUNAN BETTER, Livzon Pharmaceutical and Wanbang Biopharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Statin Industry, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Statin Industry, also provides the revenue of main regions and countries. Of the upcoming market potential for Statin Industry, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Statin Industry revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Statin Industry market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Statin Industry revenue, projected growth trends, production technology, application and end-user industry.

Statin Industry Segment by Company

CHIA TAI TIANQING
Zhejiang Jingxin Pharmaceutical
Shanghai Shyndec Pharmaceutical
Henan Topfond Pharmaceutical
Novartis
Merck
LUNAN BETTER
Livzon Pharmaceutical
Wanbang Biopharmaceuticals
Pfizer
Huizhi
China Resources Double-Crane Pharmaceutical
North China Pharmaceutical
Hanhui Pharmaceutical
Daiichi Sankyo
Beijing Jialin Pharmaceutical
AstraZeneca
Statin Industry Segment by Type

Astrovastatin
Pitavastatin
Rosuvastatin
Others
Statin Industry Segment by Application

Inflammatory Disorders
Cardiovascular Disorders
Obesity
Others
Statin Industry Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Statin Industry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Statin Industry and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Statin Industry.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Statin Industry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Statin Industry company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Statin Industry revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

202 Pages
1 Market Overview
1.1 Product Definition
1.2 Statin Industry Market by Type
1.2.1 Global Statin Industry Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Astrovastatin
1.2.3 Pitavastatin
1.2.4 Rosuvastatin
1.2.5 Others
1.3 Statin Industry Market by Application
1.3.1 Global Statin Industry Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Inflammatory Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Obesity
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Statin Industry Market Dynamics
2.1 Statin Industry Industry Trends
2.2 Statin Industry Industry Drivers
2.3 Statin Industry Industry Opportunities and Challenges
2.4 Statin Industry Industry Restraints
3 Global Growth Perspective
3.1 Global Statin Industry Market Perspective (2020-2031)
3.2 Global Statin Industry Growth Trends by Region
3.2.1 Global Statin Industry Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Statin Industry Market Size by Region (2020-2025)
3.2.3 Global Statin Industry Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Statin Industry Revenue by Players
4.1.1 Global Statin Industry Revenue by Players (2020-2025)
4.1.2 Global Statin Industry Revenue Market Share by Players (2020-2025)
4.1.3 Global Statin Industry Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Statin Industry Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Statin Industry Key Players Headquarters & Area Served
4.4 Global Statin Industry Players, Product Type & Application
4.5 Global Statin Industry Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Statin Industry Market CR5 and HHI
4.6.3 2024 Statin Industry Tier 1, Tier 2, and Tier 3
5 Statin Industry Market Size by Type
5.1 Global Statin Industry Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Statin Industry Revenue by Type (2020-2031)
5.3 Global Statin Industry Revenue Market Share by Type (2020-2031)
6 Statin Industry Market Size by Application
6.1 Global Statin Industry Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Statin Industry Revenue by Application (2020-2031)
6.3 Global Statin Industry Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 CHIA TAI TIANQING
7.1.1 CHIA TAI TIANQING Comapny Information
7.1.2 CHIA TAI TIANQING Business Overview
7.1.3 CHIA TAI TIANQING Statin Industry Revenue and Gross Margin (2020-2025)
7.1.4 CHIA TAI TIANQING Statin Industry Product Portfolio
7.1.5 CHIA TAI TIANQING Recent Developments
7.2 Zhejiang Jingxin Pharmaceutical
7.2.1 Zhejiang Jingxin Pharmaceutical Comapny Information
7.2.2 Zhejiang Jingxin Pharmaceutical Business Overview
7.2.3 Zhejiang Jingxin Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.2.4 Zhejiang Jingxin Pharmaceutical Statin Industry Product Portfolio
7.2.5 Zhejiang Jingxin Pharmaceutical Recent Developments
7.3 Shanghai Shyndec Pharmaceutical
7.3.1 Shanghai Shyndec Pharmaceutical Comapny Information
7.3.2 Shanghai Shyndec Pharmaceutical Business Overview
7.3.3 Shanghai Shyndec Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.3.4 Shanghai Shyndec Pharmaceutical Statin Industry Product Portfolio
7.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
7.4 Henan Topfond Pharmaceutical
7.4.1 Henan Topfond Pharmaceutical Comapny Information
7.4.2 Henan Topfond Pharmaceutical Business Overview
7.4.3 Henan Topfond Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.4.4 Henan Topfond Pharmaceutical Statin Industry Product Portfolio
7.4.5 Henan Topfond Pharmaceutical Recent Developments
7.5 Novartis
7.5.1 Novartis Comapny Information
7.5.2 Novartis Business Overview
7.5.3 Novartis Statin Industry Revenue and Gross Margin (2020-2025)
7.5.4 Novartis Statin Industry Product Portfolio
7.5.5 Novartis Recent Developments
7.6 Merck
7.6.1 Merck Comapny Information
7.6.2 Merck Business Overview
7.6.3 Merck Statin Industry Revenue and Gross Margin (2020-2025)
7.6.4 Merck Statin Industry Product Portfolio
7.6.5 Merck Recent Developments
7.7 LUNAN BETTER
7.7.1 LUNAN BETTER Comapny Information
7.7.2 LUNAN BETTER Business Overview
7.7.3 LUNAN BETTER Statin Industry Revenue and Gross Margin (2020-2025)
7.7.4 LUNAN BETTER Statin Industry Product Portfolio
7.7.5 LUNAN BETTER Recent Developments
7.8 Livzon Pharmaceutical
7.8.1 Livzon Pharmaceutical Comapny Information
7.8.2 Livzon Pharmaceutical Business Overview
7.8.3 Livzon Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.8.4 Livzon Pharmaceutical Statin Industry Product Portfolio
7.8.5 Livzon Pharmaceutical Recent Developments
7.9 Wanbang Biopharmaceuticals
7.9.1 Wanbang Biopharmaceuticals Comapny Information
7.9.2 Wanbang Biopharmaceuticals Business Overview
7.9.3 Wanbang Biopharmaceuticals Statin Industry Revenue and Gross Margin (2020-2025)
7.9.4 Wanbang Biopharmaceuticals Statin Industry Product Portfolio
7.9.5 Wanbang Biopharmaceuticals Recent Developments
7.10 Pfizer
7.10.1 Pfizer Comapny Information
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Statin Industry Revenue and Gross Margin (2020-2025)
7.10.4 Pfizer Statin Industry Product Portfolio
7.10.5 Pfizer Recent Developments
7.11 Huizhi
7.11.1 Huizhi Comapny Information
7.11.2 Huizhi Business Overview
7.11.3 Huizhi Statin Industry Revenue and Gross Margin (2020-2025)
7.11.4 Huizhi Statin Industry Product Portfolio
7.11.5 Huizhi Recent Developments
7.12 China Resources Double-Crane Pharmaceutical
7.12.1 China Resources Double-Crane Pharmaceutical Comapny Information
7.12.2 China Resources Double-Crane Pharmaceutical Business Overview
7.12.3 China Resources Double-Crane Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.12.4 China Resources Double-Crane Pharmaceutical Statin Industry Product Portfolio
7.12.5 China Resources Double-Crane Pharmaceutical Recent Developments
7.13 North China Pharmaceutical
7.13.1 North China Pharmaceutical Comapny Information
7.13.2 North China Pharmaceutical Business Overview
7.13.3 North China Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.13.4 North China Pharmaceutical Statin Industry Product Portfolio
7.13.5 North China Pharmaceutical Recent Developments
7.14 Hanhui Pharmaceutical
7.14.1 Hanhui Pharmaceutical Comapny Information
7.14.2 Hanhui Pharmaceutical Business Overview
7.14.3 Hanhui Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.14.4 Hanhui Pharmaceutical Statin Industry Product Portfolio
7.14.5 Hanhui Pharmaceutical Recent Developments
7.15 Daiichi Sankyo
7.15.1 Daiichi Sankyo Comapny Information
7.15.2 Daiichi Sankyo Business Overview
7.15.3 Daiichi Sankyo Statin Industry Revenue and Gross Margin (2020-2025)
7.15.4 Daiichi Sankyo Statin Industry Product Portfolio
7.15.5 Daiichi Sankyo Recent Developments
7.16 Beijing Jialin Pharmaceutical
7.16.1 Beijing Jialin Pharmaceutical Comapny Information
7.16.2 Beijing Jialin Pharmaceutical Business Overview
7.16.3 Beijing Jialin Pharmaceutical Statin Industry Revenue and Gross Margin (2020-2025)
7.16.4 Beijing Jialin Pharmaceutical Statin Industry Product Portfolio
7.16.5 Beijing Jialin Pharmaceutical Recent Developments
7.17 AstraZeneca
7.17.1 AstraZeneca Comapny Information
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Statin Industry Revenue and Gross Margin (2020-2025)
7.17.4 AstraZeneca Statin Industry Product Portfolio
7.17.5 AstraZeneca Recent Developments
8 North America
8.1 North America Statin Industry Revenue (2020-2031)
8.2 North America Statin Industry Revenue by Type (2020-2031)
8.2.1 North America Statin Industry Revenue by Type (2020-2025)
8.2.2 North America Statin Industry Revenue by Type (2026-2031)
8.3 North America Statin Industry Revenue Share by Type (2020-2031)
8.4 North America Statin Industry Revenue by Application (2020-2031)
8.4.1 North America Statin Industry Revenue by Application (2020-2025)
8.4.2 North America Statin Industry Revenue by Application (2026-2031)
8.5 North America Statin Industry Revenue Share by Application (2020-2031)
8.6 North America Statin Industry Revenue by Country
8.6.1 North America Statin Industry Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Statin Industry Revenue by Country (2020-2025)
8.6.3 North America Statin Industry Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Statin Industry Revenue (2020-2031)
9.2 Europe Statin Industry Revenue by Type (2020-2031)
9.2.1 Europe Statin Industry Revenue by Type (2020-2025)
9.2.2 Europe Statin Industry Revenue by Type (2026-2031)
9.3 Europe Statin Industry Revenue Share by Type (2020-2031)
9.4 Europe Statin Industry Revenue by Application (2020-2031)
9.4.1 Europe Statin Industry Revenue by Application (2020-2025)
9.4.2 Europe Statin Industry Revenue by Application (2026-2031)
9.5 Europe Statin Industry Revenue Share by Application (2020-2031)
9.6 Europe Statin Industry Revenue by Country
9.6.1 Europe Statin Industry Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Statin Industry Revenue by Country (2020-2025)
9.6.3 Europe Statin Industry Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Statin Industry Revenue (2020-2031)
10.2 China Statin Industry Revenue by Type (2020-2031)
10.2.1 China Statin Industry Revenue by Type (2020-2025)
10.2.2 China Statin Industry Revenue by Type (2026-2031)
10.3 China Statin Industry Revenue Share by Type (2020-2031)
10.4 China Statin Industry Revenue by Application (2020-2031)
10.4.1 China Statin Industry Revenue by Application (2020-2025)
10.4.2 China Statin Industry Revenue by Application (2026-2031)
10.5 China Statin Industry Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Statin Industry Revenue (2020-2031)
11.2 Asia Statin Industry Revenue by Type (2020-2031)
11.2.1 Asia Statin Industry Revenue by Type (2020-2025)
11.2.2 Asia Statin Industry Revenue by Type (2026-2031)
11.3 Asia Statin Industry Revenue Share by Type (2020-2031)
11.4 Asia Statin Industry Revenue by Application (2020-2031)
11.4.1 Asia Statin Industry Revenue by Application (2020-2025)
11.4.2 Asia Statin Industry Revenue by Application (2026-2031)
11.5 Asia Statin Industry Revenue Share by Application (2020-2031)
11.6 Asia Statin Industry Revenue by Country
11.6.1 Asia Statin Industry Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Statin Industry Revenue by Country (2020-2025)
11.6.3 Asia Statin Industry Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Statin Industry Revenue (2020-2031)
12.2 SAMEA Statin Industry Revenue by Type (2020-2031)
12.2.1 SAMEA Statin Industry Revenue by Type (2020-2025)
12.2.2 SAMEA Statin Industry Revenue by Type (2026-2031)
12.3 SAMEA Statin Industry Revenue Share by Type (2020-2031)
12.4 SAMEA Statin Industry Revenue by Application (2020-2031)
12.4.1 SAMEA Statin Industry Revenue by Application (2020-2025)
12.4.2 SAMEA Statin Industry Revenue by Application (2026-2031)
12.5 SAMEA Statin Industry Revenue Share by Application (2020-2031)
12.6 SAMEA Statin Industry Revenue by Country
12.6.1 SAMEA Statin Industry Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Statin Industry Revenue by Country (2020-2025)
12.6.3 SAMEA Statin Industry Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.